Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Astellas Pharma Inc.    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Astellas Pharma Inc.
Astellas Pharma specializes in the research, development, manufacturing and marketing of pharmaceutical products. Products are especially for immune diseases, infectious diseases, skin diseases, cancer and urologic disorders.

Net sales are distributed geographically as follows: Japan (31.2%), Asia and Oceania (8.3%), the United States (31.1%), Americas (2.4%) and Europe/Middle East/Africa (27%).

Number of employees : 16 243 people.
Sales per Businesses
20182019Delta
JPY (in Million)%JPY (in Million)%
Pharmaceutical1,300,320100%1,306,350100% +0.46%
Sales per Regions
20182019Delta
JPY (in Million)%JPY (in Million)%
United States404,40931.1%428,77632.8% +6.03%
Japan406,41431.3%376,15728.8% -7.44%
EMEA351,28027%357,01327.3% +1.63%
Asia and Oceania107,5138.3%113,5328.7% +5.6%
Americas30,6992.4%30,8702.4% +0.56%
Managers
NameAgeSinceTitle
Kenji Yasukawa592018President, CEO & Representative Director
Yoshihiko Hatanaka622018Chairman
Chikashi Takeda--Senior Executive Officer & Head-Finance
Naoki Okamura572019Representative Director & Vice President
Tomokazu Fujisawa612018Director
Hiroko Sakai592018Director
Noriyuki Uematsu592018Outside Director
Hiroo Sasaki642018Outside Director
Mamoru Sekiyama702017Independent Outside Director
Keiko Yamagami592017Independent Outside Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Stock A 0.01 1,861,787,075 1,827,147,436 98.1% 23,413,674 1.3% 98.1%
Shareholders
NameEquities%
Nomura Asset Management Co., Ltd. 98,478,786 5.29%
Nippon Life Insurance Co. 64,486,000 3.46%
BlackRock Fund Advisors 60,791,229 3.27%
Sumitomo Mitsui Trust Asset Management Co., Ltd. 56,185,600 3.02%
Nikko Asset Management Co., Ltd. 55,228,200 2.97%
The Vanguard Group, Inc. 53,278,835 2.86%
Daiwa Asset Management Co. Ltd. 48,290,287 2.59%
Norges Bank Investment Management 36,123,710 1.94%
BlackRock Japan Co., Ltd. 28,854,100 1.55%
Wellington Management Co. LLP 28,228,013 1.52%
Holdings
NameEquities%Valuation
FibroGen, Inc. (FGEN) 4,968,3675.65%207,677,741 USD
Cytokinetics, Incorporated (CYTK) 2,040,8163.45%28,448,975 USD
Astellas Pharma Inc. (4503) 1,403,2060.075%22,102,136 USD
Hokuyaku Takeyama Holdings,Inc. (3055) 1,199,0004.91%8,892,599 USD
Oncolys BioPharma Inc. (4588) 727,2005.07%7,806,957 USD
Vital KSK Holdings, Inc. (3151) 537,1360.88%5,009,583 USD
Brickell Biotech, Inc. (BBI) 12,3030.13%36,048 USD
Plus Therapeutics, Inc. (PSTV) 1900.0049%353 USD
Markets and indexes
- Tokyo Stock Exchange
- First Section
- Nikkei 225 / Stoxx Asia Pacific 50
Stock Exchange Codes
- Bloomberg Code :  4503:JP
- Reuters Code :  4503.T
- Datastream Code :  
Company contact information
Astellas Pharma Inc.
2-5-1 Nihonbashi-Honcho
JP-103-8411 Chuo-ku, Tokyo
Japan

Phone : +81 3 3244 3000
Fax : +81
Internet : http://www.astellas.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Astellas Pharma Inc.
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
ASTELLAS PHARMA INC.-10.39%28 266
JOHNSON & JOHNSON-4.19%362 446
ROCHE HOLDING AG0.67%277 253
MERCK & CO., INC-13.62%198 371
NOVARTIS-9.90%193 214
PFIZER, INC.-14.22%186 456
NOVO NORDISK A/S5.78%139 843
BRISTOL-MYERS SQUIBB COMPANY-11.36%128 734
ELI LILLY AND COMPANY7.95%128 691
AMGEN INC.-13.39%123 140
SANOFI-6.27%114 448
ASTRAZENECA PLC-7.98%113 394
ABBVIE INC.-14.85%111 326
GLAXOSMITHKLINE-14.85%93 073
CHUGAI PHARMACEUTICAL CO., LTD.4.59%65 429
BAYER AG-21.32%61 297
JIANGSU HENGRUI MEDICINE CO., LTD.1.06%59 698
ALLERGAN PLC-6.75%58 648
TAKEDA PHARMACEUTICAL COMPANY LIMITED-0.23%49 635
DAIICHI SANKYO COMPANY, LIMITED6.34%42 063
EISAI CO., LTD.1.55%19 662